
Key Points
- Tajikistan addressed e-cigarette regulation at the fourth session of the Majlisi Milli;
- Chairman Rustam Emomali stated a position supporting a ban on e-cigarettes;
- The statement covers the use, production, and circulation of e-cigarettes;
- Medical experts cited risks of severe diseases linked to excessive e-cigarette use;
- The report notes that Mexico has previously introduced similar restrictions.
2Firsts, December 16, 2025 – According to Kazinform, Tajikistan addressed the issue of electronic cigarettes during the fourth session of the Majlisi Milli, stating a position in support of prohibiting their use, production, and circulation.
Chairman Rustam Emomali said the position is aimed at protecting public health and preventing the negative effects of e-cigarette (vape) use, particularly among youth and adolescents.
The report notes that the position is based on conclusions from medical specialists, who warn that excessive use of electronic cigarettes may lead to serious illnesses, including respiratory diseases, cardiovascular conditions, and cancer.
Growing concern over the health impact of vaping was also highlighted. According to the World Health Organization, e-cigarette use increasingly affects younger populations.
The report further notes that Tajikistan is not the only country addressing the issue, citing Mexico as having previously introduced similar restrictions.
Photo source: Kazinform
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com






